Stock Events

Stock Events

Beyond Air 

0
90
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q2 2026
Next
-9.54
-7.31
-5.08
-2.85
Expected EPS
-2.8515629999999996
Actual EPS
N/A

Financials

-433.35%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
6.56MRevenue
-28.43MNet Income

Analyst Ratings

7.59Average Price Target
The highest estimate is 7.59.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 48L.MU. It's not an investment recommendation.
NVIDIA
15
NVDA
Apple
13
AAPL
Amazon
12
AMZN
Microsoft
11
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Inovio Pharmaceuticals
INO
Mkt Cap133.38M
Inovio Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines, competing in the broader biotech space with Beyond Air's focus on nitric oxide therapies.
Moderna
MRNA
Mkt Cap55.09B
Moderna, Inc. specializes in drug discovery and drug development based on messenger RNA, competing in the innovative treatment space similar to Beyond Air.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, a direct competitor in the biotech and treatments market.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals Incorporated is known for creating new possibilities in medicine to cure diseases and improve people's lives, competing with Beyond Air in the lung disease treatment space.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, competing in the same broad biopharmaceutical field as Beyond Air.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, and commercializes medicines for the treatment of serious medical conditions, directly competing with Beyond Air's therapeutic solutions.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions, competing in the biotech industry alongside Beyond Air.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics based on RNA interference, competing in the innovative treatment market similar to Beyond Air.
Biogen
BIIB
Mkt Cap32.28B
Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological diseases to patients worldwide, competing in the broader biopharmaceutical field with Beyond Air.

About

Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
Show more...
CEO
Robert Goodman
Employees
54
Country
United States
ISIN
US08862L3015
WKN
000A42FHT

Listings

MU
DE
48L.MU
STU
DE
48L.STU
BOATS
BOATS
XAIR.BOATS
F
DE
48L.F

0 Comments

Share your thoughts

FAQ

What is Beyond Air stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Beyond Air stocks are traded under the ticker 48L.MU.
When is the next Beyond Air earnings date?▼
Beyond Air is going to release the next earnings report on November 16, 2026.
What were Beyond Air earnings last quarter?▼
48L.MU earnings for the last quarter are -9.54 EUR per share, whereas the estimation was -9.36 EUR resulting in a -1.85% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Beyond Air revenue for the last year?▼
Beyond Air revenue for the last year amounts to 6.56M EUR.
What is Beyond Air net income for the last year?▼
48L.MU net income for the last year is -28.43M EUR.
How many employees does Beyond Air have?▼
As of September 04, 2026, the company has 54 employees.
In which sector is Beyond Air located?▼
Beyond Air operates in the Health & Wellness sector.
When did Beyond Air complete a stock split?▼
The last stock split for Beyond Air was on July 13, 2026 with a ratio of 1:20.
Where is Beyond Air headquartered?▼
Beyond Air is headquartered in GARDEN CITY, United States.